Advertisement
Advances in Pediatrics

Update on Pediatric Hyperthyroidism

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Leung A.K.C.
        • Leung A.A.C.
        Evaluation and management of children with thyrotoxicosis.
        Recent Pat Endocr Metab Immune Drug Discov. 2017; 11: 22-31
        • Simon M.
        • Rigou A.
        • Le Moal J.
        • et al.
        Epidemiology of childhood hyperthyroidism in france: a nationwide population-based study.
        J Clin Endocrinol Metab. 2018; 103: 2980-2987
        • Rodanaki M.
        • Lodefalk M.
        • Forssell K.
        • et al.
        The incidence of childhood thyrotoxicosis is increasing in both girls and boys in sweden.
        Horm Res Paediatr. 2019; 91: 195-202
        • Srinivasan S.
        • Misra M.
        Hyperthyroidism in children.
        Pediatr Rev. 2015; 36: 239-248
        • Kraus C.N.
        • Sodha P.
        • Vaidyanathan P.
        • et al.
        Thyroid dermopathy and acropachy in pediatric patients.
        Pediatr Dermatol. 2018; 35: e371-e374
        • Hanley P.
        • Lord K.
        • Bauer A.J.
        Thyroid disorders in children and adolescents: a review.
        JAMA Pediatr. 2016; 170: 1008-1019
        • De Leo S.
        • Lee S.Y.
        • Braverman L.E.
        Hyperthyroidism.
        Lancet. 2016; 388: 906-918
        • Rosenberg Bezalel S.
        • Elbirt D.
        • Leiba H.
        • et al.
        Isr Med Assoc J. 2017; 19: 188-192
        • Lee J.H.
        • Park S.H.
        • Koh D.G.
        • et al.
        Thyroid peroxidase antibody positivity and triiodothyronine levels are associated with pediatric Graves' ophthalmopathy.
        World J Pediatr. 2014; 10: 155-159
        • Goldstein S.M.
        • Katowitz W.R.
        • Moshang T.
        • et al.
        Pediatric thyroid-associated orbitopathy: the Children’s Hospital of Philadelphia experience and literature review.
        Thyroid. 2008; 18: 997-999
        • Kaplowitz Paul B.
        • Priya Vaidyanathan
        Update on pediatric hyperthyroidism.
        Curr Opin Endocrinol Diabetes Obes. 2020; 27: 70-76
        • Ross D.S.
        • Burch H.B.
        • Cooper D.S.
        • et al.
        2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis.
        Thyroid. 2016; 26: 1343-1421
      1. U.S. Food and Drug Administration.
        (Available at:)
        • Leger J.
        • Oliver I.
        • Rodrigue D.
        • et al.
        Consensus: Graves’ disease in children.
        Ann Endocrinol (Paris). 2018; 79: 647-655
        • Song A.
        • Kim S.J.
        • Kim M.-S.
        • et al.
        Long-term antithyroid drug treatment of graves' disease in children and adolescents: a 20-year single-center experience.
        Front Endocrino. 2021; 12: 687834
        • Jevalikar G.
        • Solis J.
        • Zacharin M.
        Long-term outcomes of pediatric Graves' disease.
        Pediatr Endocrinol Metab. 2014; 27: 1131-1136
        • Ohye H.
        • Minagawa A.
        • Noh J.N.
        • et al.
        Antithyroid drug treatment for Graves’ disease in children: a long-term retrospective study at a single institution.
        Thyroid. 2014; 24: 200-207
        • Azizi F.
        • Takyar M.
        • Madreseh E.
        • et al.
        Long-term methimazole therapy in juvenile graves' disease: a randomized trial.
        Pediatrics. 2019; 143: e20183034
        • Burch 1 H.B.
        • Wartofsky L.
        Life-threatening thyrotoxicosis. Thyroid storm.
        Endocrinol Metab Clin North Am. 1993; 22: 263-277
        • Léger J.
        Management of fetal and neonatal graves' disease.
        Horm Res Paediatr. 2017; 87: 1-6
        • Banige M.
        • Estellat C.
        • Biran V.
        • et al.
        Study of the factors leading to fetal and neonatal dysthyroidism in children of patients with Graves disease.
        J Endocr Soc. 2017; 1: 751-761
        • Yoshihara A.
        • Iwaku K.
        • Noh J.Y.
        • et al.
        Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy.
        Thyroid. 2019; 29: 128-134
        • Van der Kay D.C.
        • Wasserman J.D.
        • Palmert M.R.
        Management of newborns born to mothers with Graves’ disease.
        Pediatrics. 2016; 137: e20151878
        • Namwongprom S.
        • Dejkhamron P.
        • Unachak K.
        Success rate of radioactive iodine treatment for children and adolescent with hyperthyroidism.
        J Endocrinol Invest. 2021; 44: 541-545
        • Hudzik B.
        Zubelewicz-Szkodzinska B Antithyroid drugs during breastfeeding.
        Clin Endocrinol (Oxf). 2016; 85: 827-830